Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Spruce Biosciences Inc (NASDAQ: SPRB) closed at $0.67 in the last session, down -6.74% from day before closing price of $0.72. In other words, the price has decreased by -$6.74 from its previous closing price. On the day, 1.22 million shares were traded. SPRB stock price reached its highest trading level at $0.7079 during the session, while it also had its lowest trading level at $0.6618.
Ratios:
We take a closer look at SPRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.67. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on March 14, 2024, Downgraded its rating to Sector Perform and sets its target price to $2 from $9 previously.
On March 14, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $9 to $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 21 ’24 when Novo Holdings A/S sold 465,021 shares for $0.75 per share. The transaction valued at 350,951 led to the insider holds 2,550,000 shares of the business.
Novo Holdings A/S sold 359,979 shares of SPRB for $264,081 on Mar 20 ’24. The 10% Owner now owns 3,015,021 shares after completing the transaction at $0.73 per share. On Mar 19 ’24, another insider, Novo Holdings A/S, who serves as the 10% Owner of the company, sold 593,000 shares for $0.76 each. As a result, the insider received 447,715 and left with 3,375,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRB now has a Market Capitalization of 29742542 and an Enterprise Value of -49263664. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.74 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at -4.865 whereas that against EBITDA is 0.959.
Stock Price History:
Over the past 52 weeks, SPRB has reached a high of $5.95, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is -10.20%, while the 200-Day Moving Average is calculated to be -66.80%.
Shares Statistics:
According to the various share statistics, SPRB traded on average about 1.35M shares per day over the past 3-months and 599700 shares per day over the past 10 days. A total of 41.03M shares are outstanding, with a floating share count of 28.37M. Insiders hold about 31.08% of the company’s shares, while institutions hold 27.58% stake in the company. Shares short for SPRB as of 1715731200 were 123300 with a Short Ratio of 0.09, compared to 1713139200 on 163978. Therefore, it implies a Short% of Shares Outstanding of 123300 and a Short% of Float of 0.32.
